ArticleESMO gastrointestinal oncology2024

Age-related outcomes in MSI/dMMR gastrointestinal cancers treated by immune checkpoint inhibitors and toxicity's impact on efficacy: an immunoMSI cohort study.

L Mailly-Giacchetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.